Nasal Spray Peptides
Educational guide on peptides studied in intranasal form: data, limitations, and evidence levels.
What Are Nasal Spray Peptides
Nasal spray peptides are an alternative route of administration that utilizes the richly vascularized nasal mucosa. This route is studied primarily for small molecular weight peptides (<1 kDa) that may potentially bypass the blood-brain barrier via the olfactory nerve.
Quick Dosage Reference
Summary of studied dosages across all nasal spray peptides. These are research-reported doses — not prescribing guidance. Click a peptide name for its full protocol.
| Peptide | Category | Studied Dose | Frequency | Per Spray | Evidence |
|---|---|---|---|---|---|
| Semax | Cognitive | 200–600 mcg/day | 2–3×/day | 0.1 mL | Strong Evidence |
| Selank | Anxiolytic | 250–500 mcg × 3/day | 3×/day | 0.1 mL | Strong Evidence |
| Oxytocin | Social / Hormonal | 24–40 IU | 1×/day | 4 IU/spray | Strong Evidence |
| Desmopressin | Hormonal | 10–40 mcg/day | 1–2×/day | 10 mcg/spray | Strong Evidence |
| PT-141 | Sexual | 20 mg (historical) | Single dose | 0.1 mL | Investigational |
| BPC-157 | Healing | 200–500 mcg × 2–3/day | 2–3×/day | ~100 mcg/spray | Investigational |
| TB-500 | Healing | 250–750 mcg × 1–2/day | 1–2×/day | 0.1 mL | Investigational |
| VIP | Immune / Respiratory | 50–100 mcg × 4/day | 4×/day | 50 mcg/spray | Limited |
| Exendin-4 | Metabolic | N/A | N/A | N/A | Investigational |
| Leptin | Metabolic | N/A | N/A | N/A | Limited |
N/A = No established human dosage data available. All doses are from published research — not clinical recommendations.
Evidence Levels
Spray Peptides
Educational overview — no usage or preparation instructions
What are intranasal peptides
Certain peptides and neuropeptides have been studied in nasal spray form as an alternative route of administration. Intranasal delivery involves applying a formulation to the nasal mucosa, aiming for local or systemic absorption. Only a few peptides have approved nasal formulations, while the majority remain at a research or early experimental stage.
Why intranasal delivery attracts research interest
- •The nasal cavity offers rich vascularization and thin epithelium, which theoretically facilitates absorption of small molecules.
- •For certain neuropeptides, the possibility of partial CNS access via the olfactory nerve has been discussed, although the exact mechanism remains under investigation.
- •The non-invasive nature of administration (no injection) represents a practical advantage in research settings.
- •Bioavailability depends significantly on molecular weight, lipophilicity, and formulation composition — it is not guaranteed for every peptide.
Compounds with stronger intranasal relevance
The following compounds have approved formulations or extensive clinical data in nasal form:
Approved drug (FDA, EMA) in nasal spray form for central diabetes insipidus and nocturnal enuresis. Has full clinical documentation and commercial formulations.
Extensively studied in nasal form across hundreds of clinical trials (social cognition, autism, psychiatry). Commercial nasal formulations are available in certain countries (e.g. Syntocinon Spray). Use for psychiatric indications is not FDA-approved.
Approved in Russia as a nasal spray for cognitive enhancement. Research data primarily from Russian clinical studies — no large Western clinical trials exist. Not approved by FDA or EMA.
Approved in Russia as an anxiolytic in nasal form. Research data suggests anxiolytic activity in clinical trials. Not approved by FDA or EMA.
Compounds with investigational or limited relevance
The following compounds have been discussed in a research context but do not have approved nasal formulations:
Originally developed as a nasal spray but development was discontinued due to cardiovascular concerns (blood pressure increase). Eventually approved only as a subcutaneous injection (Vyleesi). The nasal form is no longer under development.
GLP-1 receptor agonist. The subcutaneous form (Exenatide) has documented efficacy. The nasal form has investigational relevance for potential central action, but no approved nasal formulation exists.
Adipose tissue hormone (16 kDa) involved in energy balance regulation. Intranasal delivery is at a very early research stage with minimal published data. The large molecular weight represents a significant bioavailability barrier.
Key limitations of intranasal peptide delivery
- •Nasal bioavailability of peptides is generally low and depends on molecular weight — large proteins are poorly absorbed.
- •Formulation stability (pH, preservatives, absorption enhancers) significantly affects efficacy.
- •CNS access via the nasal route is not guaranteed — data varies depending on the compound.
- •Much of the available research data comes from small-sample studies or specific geographic regions (e.g. Russian studies for Semax/Selank).
- •Self-preparation of nasal spray from powder or injectable solution carries risks of contamination, dose inaccuracy, and formulation instability.
Safety & Evidence Disclaimer
The content of this section is strictly informational and educational. It does not constitute medical advice, does not encourage use, and does not replace the judgment of a qualified healthcare professional.
The evidence levels referenced (stronger relevance, investigational, limited) reflect the degree of published research on intranasal delivery and do not constitute an assessment of efficacy or safety.
No preparation, self-administration, or dosage instructions are provided. Use of any substance should be exclusively under medical supervision and within a legal framework.
Key Limitations
- •Bioavailability varies significantly between compounds
- •Stability in aqueous solution may be limited
- •Larger peptides (>3 kDa) show poor absorption
- •Clinical data for most remain investigational
- •Nasal congestion affects absorption
Related Protocols
Related Articles
This page does not include self-administration instructions. Information is educational.
Θέλετε νέα updates;
Want future updates?
Ακολουθήστε το επίσημο κανάλι του AllPeptides.eu στο Telegram για νέα guides, updates και επόμενα εργαλεία της πλατφόρμας.
Follow the official AllPeptides.eu Telegram channel for new guides, updates and upcoming platform tools.
Open Telegram ChannelImportant Disclaimer
The content of this website is provided exclusively for informational and educational purposes within the context of research literature.
Read the full Disclaimer →